The Calcineurin Inhibitor Tacrolimus as a New Therapy in Severe Cherubism
Natacha Kadlub(Délégation Paris 5), Amélie E. Coudert(Inserm), Marcel Deckert(Inserm), Sandrine Marlin(Hôpital Necker-Enfants Malades), Aurore Coulomb L’Herminé(Sorbonne Université), Arnaud Picard(Hôpital Necker-Enfants Malades), Linda Dainese(Heidelberg University), Tim Ulinski(Sorbonne Université), Louise Galmiche(Délégation Paris 5), Brigitte Fauroux(Hôpital Necker-Enfants Malades), Nicolas Leboulanger(Hôpital Necker-Enfants Malades), Ioana Pavlov(Hôpital Necker-Enfants Malades), Ariane Berdal(Inserm), Vianney Descroix(Inserm), Marie‐Paule Vazquez(Université Paris Cité), Cécile Badoual(Inserm)
Cited by 45
Related Papers
KCNQ4, a Novel Potassium Channel Expressed in Sensory Outer Hair Cells, Is Mutated in Dominant Deafness
|Cell|1999|868
GJB2 Mutations and Degree of Hearing Loss: A Multicenter Study
|The American Journal of Human Genetics|2005|558
Targeting Cancer Cell Metabolism: The Combination of Metformin and 2-Deoxyglucose Induces p53-Dependent Apoptosis in Prostate Cancer Cells
|Cancer Research|2010|528
The immune paradox of sarcoidosis and regulatory T cells
|The Journal of Experimental Medicine|2006|444
Role of Propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma
|International Journal of Pediatric Otorhinolaryngology|2009|235